Other

Intrinsic value of stock options exercised

Vertex Pharmaceuticals Intrinsic value of stock options exercised remained flat by 0.0% to $36.95M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 31.0%, from $28.20M to $36.95M. Over 2 years (FY 2023 to FY 2025), Intrinsic value of stock options exercised shows an upward trend with a 7.3% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityVolatile
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

High intrinsic value realized suggests strong stock performance and significant compensation payout to employees.

Detailed definition

The total intrinsic value realized by employees upon the exercise of their stock options during the period. Intrinsic va...

Peer comparison

Standard disclosure for companies with significant stock option programs.

Metric ID: other_share_based_compensation_arrangement_by_share_base_f4d743

Historical Data

3 years
 FY'23FY'24FY'25
Value$128.40M$112.80M$147.80M
YoY Change-12.1%+31.0%
Range$112.80M$147.80M
CAGR+7.3%
Avg YoY Growth+9.4%
Median YoY Growth+9.4%

Frequently Asked Questions

What is Vertex Pharmaceuticals's intrinsic value of stock options exercised?
Vertex Pharmaceuticals (VRTX) reported intrinsic value of stock options exercised of $36.95M in Q4 2025.
How has Vertex Pharmaceuticals's intrinsic value of stock options exercised changed year-over-year?
Vertex Pharmaceuticals's intrinsic value of stock options exercised increased by 31.0% year-over-year, from $28.20M to $36.95M.
What is the long-term trend for Vertex Pharmaceuticals's intrinsic value of stock options exercised?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's intrinsic value of stock options exercised has grown at a 7.3% compound annual growth rate (CAGR), from $128.40M to $147.80M.
What does intrinsic value of stock options exercised mean?
Total value gained by employees from exercising stock options.